EMN for Traceability in Laboratory Medicine

Laboratory testing is at the heart of modern health care: an estimated 70% of medical decisions depend on in vitro diagnostics (IVDs). Benefits for patients, healthcare providers and the IVD industry are improved when robust and metrologically traceable IVDs are used to provide accurate test results irrespective of the laboratory, the IVD provider, or the instrumentation used for testing.

Metrological traceability of IVDs enhances validity of diagnosis, supports further treatment, and lowers the financial burden on healthcare systems by avoiding nonessential testing. Traceability is also an important aspect of regulatory schemes: IVD manufacturers need to comply with legal requirements for traceability to gain and maintain market access.

These requirements are defined in the regulation on in vitro diagnostic medical devices EU 2017/746 (IVDR) and include metrological traceability of calibrator and control material values along with testing of highrisk IVDs by EU reference laboratories. The European network on Traceability in Laboratory Medicine (TraceLabMed) was established to build a coordinated metrologybased quality infrastructure in an area that affects almost every European citizen.

For download: Overview of EMN TraceLabMed (PDF)

EMN Chair

Rainer Stosch, PTB, Germany

TLM News

See all EURAMET news
The NIBSC, a member of TraceLabMed, supports vital COVID-19 research
04-08-20
Developing reference materials and standards to fight against the spread of the coronavirus
TraceLabMed and EMPIR projects make vital contributions to COVID-19 testing
03-08-20
European metrology institutes from EURAMET’s TraceLabMed network provide essential support for COVID-19 viral and antibody testing
Members of Traceability in Laboratory Medicine network support COVID-19 response
31-07-20
EMN TraceLabMed members contribute to improving the accuracy and quality of coronavirus testing procedures